Document Detail

Feasibility of photopheresis to reduce the occurrence of restenosis after percutaneous transluminal coronary angioplasty: a clinical pilot study.
MedLine Citation:
PMID:  11526359     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Photopheresis was evaluated as a means of preventing restenosis on the basis of immune modulation. METHODS: This was a prospective, randomized, controlled clinical trial analyzing clinical restenosis at 6 months after percutaneous transluminal coronary angioplasty (PTCA). Seventy-eight patients with single-vessel angioplasty were randomly assigned to a control group of 41 patients and a treatment group of 37 patients. At 6 months, there were 72 evaluable patients: 39 control patients and 33 treated. Twenty-nine control patients received balloon PTCA only and 10 patients received stents. Twenty treated patients received PTCA only and 13 patients received stents. Baseline clinical characteristics of both groups were similar. The treatment group received photopheresis for a total of 5 treatments. Primary end points were death from any cause, myocardial infarction, ischemia, and repeat revascularization procedures. RESULTS: By intention-to-treat analysis, clinical restenosis occurred in 27% of control patients versus 8% of treated patients (P =.040, relative risk = 0.30). CONCLUSIONS: Photopheresis therapy in patients undergoing balloon PTCA with and without stent deployment has been shown to be effective in reducing restenosis. The use of photopheresis in such patients merits further investigation.
E Bisaccia; A S Klainer; J Gonzalez; J Schwartz; D Randazzo; L C Antonucci; C A Shioleno; H J Eisen; J S Banas
Related Documents :
21658899 - Effect of light-emitting diode (led) therapy on the development of osteoarthritis (oa) ...
22933669 - Gender-specific high-flexion knee prosthesis in indian women: a prospective randomised ...
18317669 - Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospe...
2353619 - Quantitative analysis of 123i-meta-iodobenzylguanidine (mibg) uptake in hypertrophic ca...
21046279 - The effect of various forms of selenium supplied to pregnant goats on the levels of sel...
22121129 - Golimumab in combination with methotrexate in japanese patients with active rheumatoid ...
24495529 - Feasibility of using the predisposition, insult/infection, physiological response, and ...
21704289 - Comparison of risk scores to estimate perioperative mortality in aortic valve replaceme...
1361859 - A review of urea and creatinine kinetics in predicting capd outcome.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  American heart journal     Volume:  142     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-08-29     Completed Date:  2001-09-20     Revised Date:  2006-02-27    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  461-5     Citation Subset:  AIM; IM    
Morristown Memorial Hospital, Department of Cardiovascular Medicine, and Section of Photopheresis, Morristown, NJ, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Disease / pathology,  surgery*
Middle Aged
Myocardial Infarction
Myocardial Ischemia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior c...
Next Document:  Value of the Bruce protocol to determine peak exercise oxygen consumption in patients evaluated for ...